Franklin Resources’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
Sell
-836,515
Closed -$4.22M 1583
2015
Q4
$4.22M Sell
836,515
-4,226,228
-83% -$21.3M ﹤0.01% 1165
2015
Q3
$17.8M Sell
5,062,743
-1,512,209
-23% -$5.32M 0.01% 876
2015
Q2
$65.6M Sell
6,574,952
-153,642
-2% -$1.53M 0.03% 515
2015
Q1
$85.7M Buy
6,728,594
+1,384,094
+26% +$17.6M 0.04% 439
2014
Q4
$75.6M Buy
5,344,500
+435,211
+9% +$6.16M 0.03% 462
2014
Q3
$67.5M Buy
4,909,289
+1,962,389
+67% +$27M 0.03% 487
2014
Q2
$45.3M Sell
2,946,900
-95,500
-3% -$1.47M 0.02% 632
2014
Q1
$51.8M Buy
3,042,400
+657,100
+28% +$11.2M 0.02% 563
2013
Q4
$30.9M Sell
2,385,300
-384,600
-14% -$4.98M 0.02% 692
2013
Q3
$28M Buy
2,769,900
+522,600
+23% +$5.28M 0.01% 715
2013
Q2
$16.8M Buy
+2,247,300
New +$16.8M 0.01% 802